Oxidative stress-induced mitochondrial function and cell apoptosis to osteoblasts, plays a critical role in the pathophysiology of osteoporosis. However, mechanisms underlying such process remain not yet clear. We aims in this study to investigate a possible role of SMAD (the mothers against decapentaplegic homolog 4 (SMAD4) in the oxidative stress-induced apoptosis, in homo sapiens osteoblast hFOB1.19 cells. Results demonstrated that the treatment with more than 100 μM H 2 O 2 significantly downregulated the cellular viability, whereas markedly induced apoptosis in hFOB1.19 cells. The SMAD4 was markedly reduced in both mRNA and protein levels in the H 2 O 2 -treated hFOB1.19 cells, along with the reduction of Small ubiquitin-related modifier 1 (SUMO 1) and SUMO 2/3. The immunoprecipitation assay confirmed indicated the interaction between SUMO 1 (or SUMO 2/ 3) and SMAD4. Moreover, the SMAD4 overexpression markedly ameliorated the H 2 O 2 -resulted viability reduction and apoptosis induction in hFOB1.19 cells. Interestingly, such amelioration was blocked by the knockdown of SUMO 2/3. Taken together, we conclued that SMAD4 inhibits the H 2 O 2 -induced apoptosis in osteoblast hFOB1.19 cells; such inhibition might depend on the SUMOylation by SUMO 2/3. It implies a promising role of SMAD4 in oxidative stress-promoted damage to osteoblasts.
Introduction
Reactive oxygen species (ROS) are products of aerobic respiration. Upregulated levels of ROS, beyond cellular anti-oxidant capacity, occur as a consequence of cellular anti-oxidant enzymes, toxins, pharmacological agents, or ultraviolet (UV) irradiation [1] [2] [3] . Excess ROS can oxidize cellular lipids, proteins, DNA and carbohydrates, and it is implicated in a number of human diseases as well as osteoporosis [4, 5] .
Four mammalian small ubiquitin-related modifiers (SUMO 1-4) have been identified, three of which, SUMO 1, SUMO 2, and SUMO 3, are functionally characterized [6, 7] . SUMO 2 and SUMO 3 are 95% identical in sequence, and are 50% homologous with SUMO 1 [8] . Sumoylation can impact the transcription factor by modifying protein conformation, protein-cofactor interaction, DNA binding, and ligand binding [9] .
Bone is composed of multiple cell types including osteoclasts, osteoblasts, and osteocytes, which is responsible for renewal and repair [10] . During this process, osteoblasts generate collagen for formating new bone [11] . Mothers against decapentaplegic homolog 4 (SMAD4) SMAD 4 is a major transducer of bone morphogenetic protein (BMP) and transforming growth factor-β (TGF-β) signaling pathways that regulates mitochondrial function and apoptosis [12] . SMAD 4 protein is modified in post-translational level by SUMO proteins in the TGF-β/ activin signaling pathway, such as SUMO-1-3 [10] . However, to date, it remains unclear whether SMAD 4 is necessary for the viability regulation on osteoblasts and osteocytes, and what a role of SMAD 4 plays in the oxidative stress (OS)-induced osteoporosis.
In this research, we tried to investigate a possible role of SMAD family member 4 in the OS-induced apoptosis. We found that SMAD4 expression was markedly reduced in the H 2 O 2 -treated osteoblast hFOB1.19cells, along with the reduction of SUMO 1 and SUMO 2/3. We concluded that SMAD4 inhibited the H 2 O 2 -induced apoptosis by SUMO 2/3-based SUMOylation. It indicates a promising role of SMAD4 in oxidative stress-promoted damage to osteoblasts.
Materials and methods

Cell culture and transfection
Osteoblast hFOB1. 19 10% fetal bovine serum (FBS) (Gibco, Rockville, MD, USA). Transfection was performed by lipofectamine 2000 (Thermo Scientific, Rockford, IL, USA).
Immunoprecipitation assay
To detect the interaction between SUMO 1 or SUMO 2/3 with SMAD4 in hFOB1.19 cells, 85%-confluent hFOB1.19 cells were lyzed and subjected to 10% gel electrophoresis. Immunoprecipitation (IP) with anti-SMAD4 antibody or normal mouse IgG (negative control) was performed firstly, then the immunoblot (IB) using mouse monoclonal antibody against SUMO 1 (with a dilution of 1:1000; Santa Cruz Biotechnology, Santa Cruz, CA, USA) or mouse monoclonal antibody against SUMO 2/3 antibody (with a dilution of 1:1000; Santa Cruz Biotechnology, Santa Cruz, CA, USA) was performed respectively.
Real-time quantitative PCR (RT-qPCR)
Total mRNA samples were isolated using the kit for mRNA Isolation and Purification (Clontech, Palo Alto, CA, USA). Each mRNA sample was firstly reverse transcribed using the First Strand cDNA Synthesis Kit (Invitrogen, Carlsbad, CA, USA) according to the kit's instruction. RTqPCR was performed with the Maxima SYBR Green/ROX qPCR Master Mix (2X) (Thermo Fisher Scientific, Waltham, MA, USA) using primers as previously described [9] . Briefly, cDNA (2 μl) was added into the 20 μl RT-qPCR reaction. RT-qPCR was performed under following 
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Cytokine 102 (2018) [173] [174] [175] [176] [177] [178] [179] [180] conditions: 10 min at 95°C, followed by 35 cycles of 15 s at 95°C, 30 s at 58°C and 25 s at 72°C, another 10 mins at 72°C for the final extension and keeping at 4°C. Target mRNA level was calculated by ABI Software Manager (ABI, USA).
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay
85%-confluent hFOB1.19 cells were planted in six-well plates and then were treated with 0, 25 or 100 μM H 2 O 2 for 4 hours. Then cells were updated with the culture medium containing 2% FBS (with antibiotics) and were cultured for an additional 4 h. Finally, the apoptotic cells were stained by using Apoptosis TUNEL Assay (Roche Diagnostics, GmbH, Germany) under the guidance of its protocol. Cell apoptosis was observed under the Olympus FV500 confocal fluorescence microscope (Olympus, Tokyo, Japan) and was analyzed using Fluoview software v.5.0 (Olympus, Tokyo, Japan).
SDS-PAGE and western blotting
hFOB1.19 cells suspending in PBS were exposed to Mitochondria/ Cytosol Fractionation Kit (Abcam, Cambridge, UK) to isolate the mitochondrial or cytosolic proteins. Cellular lysate was centrifuged with 12,000g for 15 min at 4°C, and the supernatant was collected and was stored at -80°C before use. Equal amounts of protein samples were added with equal amount of 2x SDS-PAGE loading buffer and were subjected to SDS-PAGE electrophoresis. The separated protein samples were transferred to a polyvinylidene fluoridehydrophobic membrane (Millipore, Bedford, MA, USA), which was blocked with 2% bovine serum albumin (BSA) in PBST. Western blotting was performed using rabbit poloclonal antibody against Cytochrome c (Cyt c) (dilution = 1:500, Santa Cruz Biotechnology, Santa Cruz, CA, USA), against SMAD4 (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA, USA), against caspase 3 (Casp 3) (dilution = 1:500, Santa Cruz Biotechnology, Santa Cruz, CA, USA), against Poly (ADP-ribose) polymerase (PARP) (dilution = 1:500, Santa Cruz Biotechnology, Santa Cruz, CA, USA), against SUMO 1 (dilution = 1:1000, Santa Cruz Biotechnology, Santa Cruz, CA, USA) or against SUMO 2/3 (dilution = 1:1000, Santa Cruz Biotechnology, Santa Cruz, CA, USA) as the first antibody respectively. Then horseradish peroxidase (HRP)-conjugated goat anti-rabbit antibody (Bio-Rad Laboratories, Hercules, CA, USA) and the Enhanced chemiluminescence (ECL) (RPN2106, Amersham Pharmacia Biotech, Amersham, UK) were usedto visualize and to quantify each protein band.
Cell apoptosis assay
Cell apoptosis assay was performed by using the Annexin V-FITC Apoptosis Detection Kit (MERK Millipore, USA) as the tutorial described [10] . In briefly, the H 2 O 2 -treated hFOB1.19 cells were centrifugated at 1000 xg for 5 minutes and washed twice with ice-cold Phosphate Buffer Solution (PBS), then the cells were suspended in the 400 μl 1× Binding Buffer at a concentration of 1x10 5 cells/ml, then the cell suspension was added in turn with 5 μl of Annexin V-FITC and Propidium Iodide for an incubation in the dark at room temperature for 10 minutes. Finally, the stained cells were subject to flow cytometry analysis. 
Statistical analysis
Comparisons among treatment groups were made with the paired t test (two groups) or the repeated measures of analysis of variance (more than two groups). Multiple pairwise comparisons were made with the Tukey's studentized range test. All p values are two-tailed and considered significant when < 0.05. Fig. 1A , cells viable rates were decreased by 25%, 30% and 50%, when were treated by 50 μM, 100 μM and 200 μM respectively, with statistical differences. In the next, we checked apoptotic rates of the treated cells. Obviously, 100 μM and 200 μM H 2 O 2 treatments upregulated the apoptotic rate by 1.6 times and 2.4 times separately, with statistical differences. release of Cytochrome c from mitochondria (Cytosol Cyt c), cleaved caspase 3 (Cleaved Casp 3) and the lyzed PARP by caspase 3 in hFOB1.19 cells post the H 2 O 2 treatment were evaluated by western blot (Fig. 1C) , significant higher levels of Cytosol Cyt c (p < 0.05 or p < 0.01, Fig. 1D ), Cleaved Casp 3 (p < 0.01 or p < 0.0001, Fig. 1E ) and Lyzed PARP (p < 0.01 or p < 0.001, Fig. 1F) confocal microscopy ( Fig. 2A-C) . We calculated the TUNEL-positive cells, as indicated in Fig. 2D , 50 or 100 μM H 2 O 2 treatment group presents significantly higher TUNEL-positive cells than the control group (p < 0.01 or p < 0.001), also dose-dependently (p < 0.001).
Results
3.1·H
3.3·H2O2 treatment suppressed the expression levels of SMAD4, SUMO 1 and SUMO 2/3
About 85%-confluent hFOB1.19 cells were treated with 0, 25, 50, 100 or 200 μM H 2 O 2 for 4 hours, and then were replaced by the fresh medium (2% FBS) for 20 hours, the relative mRNA levels of SMAD4, SUMO 1 and SUMO 2/3 were examined with real time quantitative PCR method, and were presented as the relative value to the mRNA level of internal reference β-actin. As shown in Fig. 3A , 100 μM and 200 μM H 2 O 2 treatment decreased relative SMAD4 mRNA level by 20% and 40% respectively with statistical differences (p < 0.05 or p < 0.001), dose-dependently (p < 0.05).
Regarding the SUMO 1 and SUMO 2/3, SUMO 1 treatment did not suppress the relative SUMO 1 level to β-actin, and SUMO 2/3 levels were down-regulated by 30% and 40% respectively, when cells were treated by 100 μM or 200 μM H 2 O 2 (either p < 0.01, Fig. 3B ). The protein levels of the three proteins were also analyzed by western blotting assay (Fig. 3C) , obviously, expression levels of SMAD4 and SUMO 2/3 were severely depressed under the 100 μM or 200 μM H 2 O 2 treatment.
Sumoylation of SMAD4 by SUMO 1, 2/3 in hFOB1.19 cells
To detect the interaction between SUMO 1 or SUMO 2/3 with SMAD4 in hFOB1.19 cells, 85%-confluent hFOB1.19 cells were lyzed for immunoprecipitation (IP) with anti-SMAD4 antibody or normal mouse IgG (negative control). As indicated in Fig. 4A and 4B, anti-SMAD4 antibody recognized the complex of SMAD4-SUMO 1 and the complex of SMAD4-SUMO 2/3, respectively. The results indicate SUMO 1 and SUMO 2/3 sumoylate the SMAD4.
3.5. Overexpression of SMAD4 ameliorated the oxidative stress-induced apoptosis of hFOB1.19 cells 85%-confluent hFOB1.19 cells were transfected with control pcDNA3.1(+) or expression plasmid SMAD4-pcDNA3.1(+) for 6 hours, and then were treated with 0 or 100 μM H 2 O 2 for 4 hours, and then were replaced by the medium (2% FBS) without H 2 O 2 for another 20 h, then the SMAD4 mRNA level was examined with RT-qPCR. As indicated in Fig. 5A and 5B, the mRNA levels of SMAD4, SUMO 1 and SUMO 2/3 were examined, and we found that SMAD4-pcDNA3.1(+) transfection up-regulated the SMAD4 expression with/without H 2 O 2 treatment (either p < 0.0001). In addition, we checked the apoptotic rates of treated cells and found that SMAD4-pcDNA3.1(+) transfection decreased the apoptotic rate induced by H 2 O 2 (100 μM) by 40% (p < 0.01, Fig. 5C ). TUNEL assay also indicated that TUNEL positive cells per field by SMAD4-pcDNA3.1(+) transfection were suppressed by 50% (p < 0.01, Fig. 5D and 5E ).
3.6. SUMO 1/2 knockdown with siRNA improved the anti-apoptotic effect of SMAD4 in hFOB1.19 cells 85%-confluent hFOB1.19 cells were transfected with pcDNA3.1(+) or SMAD4-pcDNA3.1(+) for 3 hours, and then were transfected with 60 nM control siRNA (siRNA-Ctrl), SUMO 1-(siRNA-SUMO 1) or SUMO 2/3-specific siRNA (siRNA-SUMO 2/3) for another 6 hours, and then were treated with 0 or 100 μM H 2 O 2 for 4 hours, and finally were updated with the fresh medium containing 2% FBS for another 20 hours. The mRNA levels of SUMO 1 or SUMO 2/3 were examined with RT-PCR, siRNA-SUMO 1 decreased the relative SUMO 1 mRNA level, siRNA-SUMO 2/3 reduced the SUMO 2/3 mRNA level either by 50% (either p < 0.01, Fig. 6A and 6B) . Western Blotting assay also indicated that siRNA-SUMO 1 and siRNA-SUMO 2/3 repressed the expressions of SUMO 1 and SUMO 2/3 respectively (Fig. 6C) . Moreover, we checked the apoptotic rate of siRNA and pcDNA3.1 transfected cells, we found that siRNA-SUMO 1 and siRNA-SUMO 2/3 significantly inhibited the SMAD4-mediated apoptosis decrease in the H 2 O 2 -treated hFOB1.19 cells (either p < 0.01, Fig. 6D ).
Discussion
In the research, we demonstrated that the treatment with more than 100 μM H 2 O 2 significantly reduced the cellular viability and induced apoptosis in hFOB1.19 cells. The SMAD4 was markedly reduced in both mRNA and protein levels in the H 2 O 2 -treated hFOB1.19 cells, along with the reduction of Small ubiquitin-related modifier 1 (SUMO 1) and SUMO 2/3. The immunoprecipitation assay confirmed the interaction between SUMO 1 (or SUMO 2/3) and SMAD4. Further, the SMAD4 overexpression markedly ameliorated the H 2 O 2 -resulted viability reduction and apoptosis induction in hFOB1.19 cells. Such amelioration was blocked by the knockdown of SUMO 2/3.
Although SMAD 4 is known to regulate apoptosis in a variety of cells [13, 14] , it is not known whether SMAD 4 is involved in regulating the viability of mature osteoblasts. In our findings, SMAD4 overexpression ameliorated the oxidative stress-induced apoptosis of hFOB1.19 cells. Interestingly, such amelioration was repressed by the inhibition of SUMO 2/3 (Fig. 5C ). In addition, apoptosis was improved by transfection of siRNA-SUMO 1 and siRNA-SUMO 2/3 in osteoblast cells with SMAD 4-overexpressed (Fig. 6C) . It implies that the interaction between SMAD 4 and SUMOs involved in such apoptosis regulation. It was reported that SMAD-dependent BMP signaling induces apoptosis through the mitochondrial pathway in mature osteoblast cells [12] . Our finding suggests the apoptotic function of SMAD 4 in mature osteoblasts in vitro is associated with the SUMOylation of it by SUMO1 or 2/3.
Oxidative stress is responsible for the impaired SMAD 2 or 3 in mouse heart. signaling in the developing mouse heart [15] . We found the SMAD 4 reduction by the H 2 O 2 treatment in hFOB1.19 cells. However, the mechanism by which oxidative exposure selectively reduces SMAD 4 protein levels remains to be determined [16] . SMAD 4- Fig. 6 . Regulation by the SUMO 1/2 knockdown with siRNA on the anti-apoptotic effect of SMAD4 in hFOB1.19 cells. 85%-confluent hFOB1.19 cells were transfected with pcDNA3.1(+) or SMAD4-pcDNA3.1(+) for 3 hours, and then were transfected with 60 nM control siRNA (siRNA-Ctrl), SUMO 1-(siRNA-SUMO 1) or SUMO 2/3-specific siRNA (siRNA-SUMO 2/3) for another 6 hours, and then were treated with 0 or 100 μM H 2 O 2 for 4 h, and finally were updated with the medium (2% FBS) without for another 20 h. Post the transfection/treatment, the mRNA levels of SUMO 1 (A) or SUMO 2/3 (B) were examined with RT-qPCR (A), the protein levels of SMAD4, SUMO 1, SUMO 2/3 were examined with western blotting (C). The apoptosis in each group was examined with an annexin V-FITC apoptosis detection kit (E). Experiments were independently repeated in triplicate. mediated TGF-β/BMP signaling in osteoblasts may play crucial roles in determination of HSC fate in the bone marrow microenvironment [16, 17] , and sumoylated SMAD 4 is necessary for this function [18] . In our research, we also found that SMAD 4 was sumoylated, and that SUMO 1 and SUMO 2/3 formed complexes with SMAD 4. These results suggest that SUMO 1 and SUMO 2/3 are necessary for SMAD 4 sumoylation. It is unclear whether the accumulation of SUMO 1 and SUMO 2/3 are related to SMAD 4 sumoylation directly, but these findings indicate an opposite effect of sumoylation on SMAD 4 activity, which can play a positive or negative role in regulating TGF-β/SMAD signaling [19, 20] . According to results in the present study, we build a model underlining the SMAD4 signaling against the oxidative stressinduced apoptosis in osteoblasts (Fig. 7) . SMAD4 is SUMOylated by SUMO 1 or SUMO 2/3 and promotes the repairment of oxidative stressinduced DNA damage. However, oxidative stress downregulates the expression of both SMAD4 and SUMOs and inhibits SMAD4 SUMOylation. This model implies the protective role of SMAD4 in oxidative stress-induced damage to osteoblasts.
Conclusion
In conclusion, we concluded that SMAD4 inhibits the H 2 O 2 -induced apoptosis in osteoblast hFOB1.19 cells; such inhibition might depend on the SUMOylation by SUMO 2/3. It implies a promising role of SMAD4 in oxidative stress-promoted damage to osteoblasts.Compliance with ethical standards
